AB0608 WORK ABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT, RITUXIMAB, TOCILIZUMAB OR TNF INHIBITORS: A …

G Bruze, T Frisell, C Turesson, H Forsblad-D'elia… - 2024 - ard.bmj.com
Background: Rheumatoid arthritis (RA) is associated with high costs to both patients and
society due to impaired work ability. Whereas many studies have investigated differences in …

AB0607 SOLUBLE INTERLEUKIN-33 RECEPTOR (sST-2)-A NOVEL MARKER FOR ASSESSING CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS

S Patschan, I Claus, M Hoffmeister, C Remus, O Ritter… - 2024 - ard.bmj.com
Background: Rheumatoid arthritis endagers affected patients due to chronic inflammation in
the synovial joints and increased cardiovascular morbidity. The latter is a result of ongoing …

AB0606 DIGITAL BIOMARKER FOR DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING WRIST-WORN WEARABLE DEVICE-ACQUIRED SENSING DATA: A …

K Izumi, M Higashida-Konishi, S Saito, S Hama… - 2024 - ard.bmj.com
Background: Symptoms in patients with rheumatoid arthritis (RA) are potentially influenced
by exercise load and meteorological change, and often vary from day to day, especially in …